63P Efficacy and safety results by menopausal status in monarchE: Adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2- high-risk early breast cancer

Autor:	S. Paluch-Shimon, P. Neven, J. Huober, I. Cicin, Z. Jiang, M.P. Goetz, C. Shimizu, C. Huang, R.J. Wei, S.C. Nabinger, T. Forrester, N. Harbeck
Rok vydání:	2022
Předmět:	Oncology Hematology
Zdroj:	Annals of Oncology. 33:S151
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2022.03.079
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e0e943c7a41f8a768d4399414c8d8668 https://doi.org/10.1016/j.annonc.2022.03.079 Zobrazit plný text záznamu